Bradford K. Amman - 25 May 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Financial Officer
Signature: /s/ Sean McKendry as attorney-in-fact for Bradford K. Amman
Issuer symbol: VVOS
Transactions as of: 25 May 2021
Net transactions value: +$5,290
Form type: 4
Filing time: 25 May 2021, 21:45:31 UTC
Next filing: 02 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VVOS	Common Stock	Purchase	$5,290	+1,000	+100%	$5.29^*	2,000	25 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VVOS	Stock Option						100,000	25 May 2021	Common Stock	100,000	$7.50	Direct	F1
holding	VVOS	Stock Option						16,667	25 May 2021	Common Stock	16,667	$7.50	Direct	F2
holding	VVOS	Stock Option						83,334	25 May 2021	Common Stock	83,334	$7.50	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.
F2	16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
F3	83,334 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.